China Focus: China's new Alzheimer's drug completes phase 3 clinical trial

Source: Xinhua| 2018-07-17 21:19:02|Editor: Xiang Bo
Video PlayerClose

SHANGHAI, July 17 (Xinhua) -- A Chinese research group on Tuesday announced progress in developing a drug to treat Alzheimer's disease.

GV-971 was developed by Ocean University of China, Shanghai Institute of Materia Medica under Chinese Academy of Sciences and Green Valley Pharmaceutical Co., Ltd, after a 21-year study.

A phase three clinical trial is the last test before reaching the market.

In the trial, participants took 450 mg GV-971 orally twice a day for 36 weeks, which proved effective in improving cognition.

Extracted from brown algae, the drug is targeted at patients with mild-to-moderate Alzheimer's. Independent animal experiments also showed that it can regulate the immune system, reduce neuro-inflammation and improve cognition.

Alzheimer's disease is an irreversible, progressive brain disorder that slowly destroys memory, thinking skills, and the ability to carry out simple tasks. The disease affects about 48 million people worldwide, and the number is expected to increase with the aging population. There is no effective cure.

The drug opens a new avenue for treatment and provides patients with a new solution and hope, said lead researcher Geng Meiyu.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011100001373310861
国产无码在线观看免费在线,37pao国产成视频,日韩一区二区视频在线,国产国产人免费人成免费视频麻豆
日韩欧美亚洲中文综合v日本 | 在线中文字幕乱码免费视频 | 在线观看日韩精品一区二区 | 亚洲日韩欧美综合中文字幕 | 亚洲免费青草视频在线 | 亚洲中文字幕永久在线不卡 |